Asunto(s)
Neoplasias/psicología , Neoplasias/rehabilitación , Humanos , Calidad de Vida , Estados UnidosRESUMEN
This article examines the current state of the global fight against cancer and of noncommunicable disease in general, the progress to date against cancer, and postulates that there has never been a more challengingnor more idealtime to succeed in making significant headway against the disease worldwide. Based on progress made particularly in the past two decades, and with proven interventions and scientific knowledge, it is possible to bring cancer as a major health problem worldwide under control in this century.The article also discusses what the American Cancer Society, the nation's largest voluntary health organization dedicated to saving lives from cancer, is doing to lead a global movement in support of achieving this goal.
Asunto(s)
American Cancer Society , Salud Global , Neoplasias/prevención & control , Salud Pública/tendencias , Conductas Relacionadas con la Salud , Humanos , Neoplasias/economía , Neoplasias/terapia , Tasa de Supervivencia/tendencias , Estados UnidosAsunto(s)
Conducta Adictiva , Investigación Biomédica/organización & administración , National Institutes of Health (U.S.)/organización & administración , Prevención del Hábito de Fumar , Humanos , National Cancer Institute (U.S.) , National Heart, Lung, and Blood Institute (U.S.) , Cese del Hábito de Fumar , Tabaquismo , Estados UnidosRESUMEN
Substantial inequalities exist in cancer survival rates across countries. In addition to prevention of new cancers by reduction of risk factors, strategies are needed to close the gap between developed and developing countries in cancer survival and the effects of the disease on human suffering. We challenge the public health community's assumption that cancers will remain untreated in poor countries, and note the analogy to similarly unfounded arguments from more than a decade ago against provision of HIV treatment. In resource-constrained countries without specialised services, experience has shown that much can be done to prevent and treat cancer by deployment of primary and secondary caregivers, use of off-patent drugs, and application of regional and global mechanisms for financing and procurement. Furthermore, several middle-income countries have included cancer treatment in national health insurance coverage with a focus on people living in poverty. These strategies can reduce costs, increase access to health services, and strengthen health systems to meet the challenge of cancer and other diseases. In 2009, we formed the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, which is composed of leaders from the global health and cancer care communities, and is dedicated to proposal, implementation, and evaluation of strategies to advance this agenda.
Asunto(s)
Antineoplásicos/economía , Antineoplásicos/uso terapéutico , Países en Desarrollo/economía , Política de Salud , Accesibilidad a los Servicios de Salud/economía , Neoplasias , Pobreza , Colombia , Detección Precoz del Cáncer , Salud Global , Haití , Accesibilidad a los Servicios de Salud/normas , Accesibilidad a los Servicios de Salud/tendencias , Necesidades y Demandas de Servicios de Salud , Vacunas contra Hepatitis B/administración & dosificación , Humanos , Incidencia , Renta , Cobertura del Seguro , Seguro de Salud , Jordania , Malaui , Tamizaje Masivo , México , Neoplasias/diagnóstico , Neoplasias/economía , Neoplasias/epidemiología , Neoplasias/mortalidad , Neoplasias/prevención & control , Neoplasias/terapia , Vacunas contra Papillomavirus/administración & dosificación , Salud Pública , Factores de Riesgo , Rwanda , Cese del Hábito de Fumar , Factores SocioeconómicosRESUMEN
The globalization of tobacco began more than 500 years ago, but the public health response to the death, disease, and economic disruption that it has caused is fewer than 50 years old. In this report, the authors briefly trace the history of tobacco use and commerce as it moved from the Americas in the late 15th century and then eastward. They then discuss the wide range of issues that must be addressed, and the equally wide range of expertise that is needed if the global health community is to be successful in reducing, and eventually eliminating, the rising tide of tobacco use, particularly in the low- and middle-income nations that are the target of the multinational tobacco industry.
Asunto(s)
Educación en Salud/organización & administración , Mercadotecnía/organización & administración , Mercadotecnía/tendencias , Prevención del Hábito de Fumar , Fumar/epidemiología , Industria del Tabaco/tendencias , Tabaquismo/prevención & control , Adolescente , Publicidad/tendencias , Niño , Brotes de Enfermedades/prevención & control , Brotes de Enfermedades/estadística & datos numéricos , Predicción , Salud Global , Educación en Salud/métodos , Educación en Salud/tendencias , Humanos , Internacionalidad , Mercadotecnía/métodos , Nicotiana , Industria del Tabaco/legislación & jurisprudencia , Contaminación por Humo de Tabaco/prevención & control , Adulto JovenAsunto(s)
Objetivos , Directrices para la Planificación en Salud , Promoción de la Salud , Neoplasias/prevención & control , Adolescente , Adulto , Enfermedad Crónica/epidemiología , Enfermedad Crónica/prevención & control , Femenino , Salud Global , Disparidades en el Estado de Salud , Humanos , Persona de Mediana Edad , Neoplasias/epidemiología , Mercadeo Social , Naciones Unidas , Organización Mundial de la Salud , Adulto JovenAsunto(s)
Salud Global , Accesibilidad a los Servicios de Salud , Disparidades en el Estado de Salud , Disparidades en Atención de Salud , Neoplasias/etnología , Derechos del Paciente , Etnicidad , Humanos , Incidencia , Tamizaje Masivo/métodos , Neoplasias/diagnóstico , Neoplasias/etiología , Neoplasias/mortalidad , Neoplasias/terapia , Factores de Riesgo , Resultado del TratamientoRESUMEN
Cancer incidence is on the rise in many regions of the world, including the Middle East, where incidence rates for both men and women are increasing. Like many regions of the world, increased tobacco use, combined with other factors, is driving cancer incidence in the Middle East. Tobacco, the only consumer product proven to kill more than half of its regular users, will be responsible for 4.9 million deaths worldwide this year alone. That burden is fairly evenly shared by industrialized and developing nations today but, if current trends continue, the cancer burden in the developing world will more than triple in the next 25 years, resulting in a global total of 10 million deaths worldwide each year. Seven million of these deaths will occur in the developing world, in nations least prepared to deal with the financial, social, and political consequences of this global public health tragedy. In the Arab world, lung cancer is already occurring with increasing frequency, particularly among men.